What Adamas Trust ADAMH is doing that smarter investors notice 019 20260508 PFE Pfizer Inc posts 143 percent Q4 2025 EPS beat stock rises 125 percent in regular trading Celularity CELU What Lies Ahead Celularity Inc posts 425 EPS beat narrower loss Constellium CSTM Stock Investment Case 027 20260418 LBRDK Liberty beats Q3 2025 EPS estimates by nearly 40 percent yet shares fall 806 percent in todays session What Editas Medicine EDIT is building for the next decade Recovers 20260508 DORM Dorman reports minor Q4 2025 EPS miss shares edge higher as investors shrug off the small shortfall Public Service Enterprise Group PEG Q1 2026 Earnings Preview Wall Street Consensus Metrics and Upside Catalysts TVTX Q1 2026 Earnings EPS Miss as PreRevenue Biotech Ramps Up Spending SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development RDNW Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue NonDisclosure Exagen Inc Q1 2026 Earnings EPS Beat Surprises but Revenue Details Absent BRX Q1 2026 Earnings Significant EPS Beat Drives Investor Caution Pimco Global StocksPlus Income Fund PGP Edges Higher Amid Low Volatility Surf Air Mobility SRFM Shows Modest Recovery Testing Key Resistance at 130 Kronos Worldwide KRO Holds Steady Near 681 as Support and Resistance Levels Come into Focus Compass Therapeutics CMPX Breaks Out Biotech Stock Rallies 6 Toward Resistance